Eagan, MN, United States of America

Ravisankar Gurusamy

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 125(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ravisankar Gurusamy: Innovator in Medical Technology

Introduction

Ravisankar Gurusamy is a notable inventor based in Eagan, MN (US), recognized for his contributions to medical technology. He holds 3 patents that reflect his innovative approach to solving complex medical challenges.

Latest Patents

One of his latest patents is for a method of measuring pressures in the coronary venous system. This method involves introducing a distal portion of a lead or tool into the coronary sinus, which includes first and second pressure sensors and at least one selectably expandable member. The expandable member is designed to isolate the sensors from each other within the coronary sinus, allowing for accurate pressure measurements. Another significant patent is for a transseptal puncture needle and needle assemblies. This invention features an elongate needle body with a cannular needle tip that has a unique design, including a wedge surface and a dome-shaped region, enhancing its functionality in medical procedures.

Career Highlights

Throughout his career, Ravisankar has worked with prominent companies in the medical field, including St. Jude Medical and Atrial Fibrillation Division, Inc. He has also been associated with Pacesetter, Inc., where he contributed to the development of innovative medical devices.

Collaborations

Ravisankar has collaborated with esteemed professionals in the industry, including Hans Schnellmann and Michael C. Bednarek. Their combined expertise has likely contributed to the success of his inventions.

Conclusion

Ravisankar Gurusamy's work exemplifies the spirit of innovation in medical technology, with his patents paving the way for advancements in patient care. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…